Literature DB >> 33423165

MSC exosome-mediated cardioprotection in ischemic mouse heart comparative proteomics of infarct and peri-infarct areas.

Rajshekhar A Kore1,2, Xianwei Wang3, Zufeng Ding4,5, Robert J Griffin6, Alan J Tackett7, Jawahar L Mehta4,5.   

Abstract

Mesenchymal stem cell (MSC) exosomes may limit cardiac injury, and even reverse cardiac damage in animal models of ischemia. To understand exosome-mediated improvement in cardiac function we examined the proteomic alternations in the MSC exosome-treated mice hearts subjected to left coronary artery (LCA) ligation, with particular emphasis on peri-infarct areas. At 7 days after LCA ligation, left ventricular end systolic thickness, infarct size and survival of mice were studied. Mass spectrometric analysis of infarct and peri-infarct areas was carried out. Expression of inflammatory markers (LOX-1 and NLRP3) and cell death markers (Bax, Bcl-2, Caspases 1 and 3 and GSDMD) were investigated by Western blots and immunofluorescence. Proteomic analysis of the infarct and peri-infarct areas in saline-treated hearts revealed differentially expressed proteins involved in inflammation and apoptotic cell death, while showing depletion of processes governing cell death. Exosome treatment significantly improved the proteomic profile in both infarct and peri-infarct areas, more so in the peri-infarct areas. The infarct size was smaller (9 ± 1%), and cardiac contractile function (fractional shortening) was preserved in the exosome-treated mice (28 ± 2%). Survival of exosome-treated mice was also better. White blood cell accumulation in and around the infarct area, expression of LOX-1 and NLRP3 inflammasome, and markers of cell death (cleaved Caspase-3, Caspase-1, GSDMD, Bcl-2 and Bax) were dramatically reduced by MSC exosome treatment (all p < 0.01). In cultured primary mouse cardiomyocytes, treatment with MSC exosomes essentially reversed inflammation-induced pro-apoptotic and inflammatory signals (p < 0.01). MSC exosomes exert their cardioprotective effects by suppressing inflammation and pro-apoptotic processes, particularly in the peri-infarct areas, resulting in preservation of cardiac function after LCA ligation.

Entities:  

Keywords:  Cardioprotection; Inflammation; Myocardial infarction; Peri-infarct area; Proteomics; Stem cell exosomes

Mesh:

Year:  2021        PMID: 33423165      PMCID: PMC8186026          DOI: 10.1007/s11010-020-04029-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity.

Authors:  Susmita Sahoo; Ekaterina Klychko; Tina Thorne; Sol Misener; Kathryn M Schultz; Meredith Millay; Aiko Ito; Ting Liu; Christine Kamide; Hemant Agrawal; Harris Perlman; Gangjian Qin; Raj Kishore; Douglas W Losordo
Journal:  Circ Res       Date:  2011-08-11       Impact factor: 17.367

2.  Stem cell-derived exosomes and the failing heart: Small cause, big effect.

Authors:  Philippe Menasché
Journal:  J Thorac Cardiovasc Surg       Date:  2018-04-13       Impact factor: 5.209

3.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2014-01-21       Impact factor: 29.690

Review 4.  Roles of exosomes in cardioprotection.

Authors:  Lucio Barile; Tiziano Moccetti; Eduardo Marbán; Giuseppe Vassalli
Journal:  Eur Heart J       Date:  2017-05-07       Impact factor: 29.983

5.  Exosomes Derived from Mesenchymal Stem Cells Rescue Myocardial Ischaemia/Reperfusion Injury by Inducing Cardiomyocyte Autophagy Via AMPK and Akt Pathways.

Authors:  Liang Liu; Xian Jin; Cui-Fen Hu; Rong Li; Zhong'e Zhou; Cheng-Xing Shen
Journal:  Cell Physiol Biochem       Date:  2017-08-25

6.  Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells.

Authors:  Kristin M Luther; Lauren Haar; Myc McGuinness; Yang Wang; Thomas L Lynch Iv; Anh Phan; Yang Song; Zilong Shen; George Gardner; Gina Kuffel; Xiaoping Ren; Michael J Zilliox; W Keith Jones
Journal:  J Mol Cell Cardiol       Date:  2018-04-23       Impact factor: 5.000

Review 7.  Induced Pluripotent Stem Cell (iPSC)-Derived Exosomes for Precision Medicine in Heart Failure.

Authors:  Phillip C Yang
Journal:  Circ Res       Date:  2018-03-02       Impact factor: 17.367

Review 8.  More Than Tiny Sacks: Stem Cell Exosomes as Cell-Free Modality for Cardiac Repair.

Authors:  Raj Kishore; Mohsin Khan
Journal:  Circ Res       Date:  2016-01-22       Impact factor: 17.367

Review 9.  Stem cell-derived exosomes - an emerging tool for myocardial regeneration.

Authors:  Erzsebet Lazar; Theodora Benedek; Szilamer Korodi; Nora Rat; Jocelyn Lo; Imre Benedek
Journal:  World J Stem Cells       Date:  2018-08-26       Impact factor: 5.326

10.  DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome.

Authors:  Yochai Birnbaum; Dat Tran; Mandeep Bajaj; Yumei Ye
Journal:  Basic Res Cardiol       Date:  2019-08-06       Impact factor: 17.165

View more
  4 in total

Review 1.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

Review 2.  Mesenchymal Stem Cell-Derived Extracellular Vesicles as Idiopathic Pulmonary Fibrosis Microenvironment Targeted Delivery.

Authors:  Lu Sang; Xiaoqin Guo; Haojun Fan; Jie Shi; Shike Hou; Qi Lv
Journal:  Cells       Date:  2022-07-28       Impact factor: 7.666

Review 3.  Exosomes and Exosomal Cargos: A Promising World for Ventricular Remodeling Following Myocardial Infarction.

Authors:  Jiacheng Fang; Yuxuan Zhang; Delong Chen; Yiyue Zheng; Jun Jiang
Journal:  Int J Nanomedicine       Date:  2022-10-04

Review 4.  Exosomes Regulate NLRP3 Inflammasome in Diseases.

Authors:  Zhangwang Li; Xinyue Chen; Junjie Tao; Ao Shi; Jing Zhang; Peng Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.